KRAS and neoplasm: As KRAS has been shown to suppress STAT1 transcription (51), we hypothesize that PTDSS1 loss impairs RAS signaling, which in turn releases the suppression of STAT1 expression, enhancing tumor cell responsiveness to IFN-γ in a cell-intrinsic manner.